Literature DB >> 28700552

First state-approved embryonic stem cell trials in China.

.   

Abstract

Mesh：

Year:  2017        PMID： 28700552     DOI： 10.1038/nbt0717-600

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  1 in total

1.  Trials of embryonic stem cells to launch in China.

Authors:  David Cyranoski
Journal:  Nature       Date:  2017-05-31       Impact factor: 49.962
  1 in total
  1 in total

1.  Preclinical safety studies of human embryonic stem cell-derived retinal pigment epithelial cells for the treatment of age-related macular degeneration.

Authors:  Sandra Petrus-Reurer; Pankaj Kumar; Sara Padrell Sánchez; Monica Aronsson; Helder André; Hammurabi Bartuma; Alvaro Plaza Reyes; Emeline F Nandrot; Anders Kvanta; Fredrik Lanner
Journal:  Stem Cells Transl Med       Date:  2020-04-22       Impact factor: 6.940
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.